Literature DB >> 2009731

Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin.

J P Rindone1, C L Kelley, W N Jones, H S Garewal, C L Keuey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009731

Source DB:  PubMed          Journal:  Clin Pharm        ISSN: 0278-2677


× No keyword cloud information.
  8 in total

1.  Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults.

Authors:  Jacques Baillargeon; Holly M Holmes; Yu-Li Lin; Mukaila A Raji; Gulshan Sharma; Yong-Fang Kuo
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

2.  The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.

Authors:  Jeffrey J Glasheen; Randolph V Fugit; Allan V Prochazka
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

3.  Drug interactions with clinafloxacin.

Authors:  E J Randinitis; C W Alvey; J R Koup; G Rausch; R Abel; N J Bron; N J Hounslow; A B Vassos; A J Sedman
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 4.  Drug interactions with quinolone antibacterials.

Authors:  J R Brouwers
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

5.  Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.

Authors:  H Schelleman; W B Bilker; C M Brensinger; X Han; S E Kimmel; S Hennessy
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

Review 6.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

7.  Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects.

Authors:  E Millar; S Coles; P Wyld; W Nimmo
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

Review 8.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.